A comparison of different staging systems predictability of patient outcome: Thyroid carcinoma as an example

Cancer

Volumn 79, Issue 12, 1997, Pages 2414-2423

  Brierley, James D ^a   Panzarella, Tony ^a   Tsang, Richard W ^a   Gospodarowicz, Mary K ^a   O'Sullivan, Brian ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Comparing staging classifications; Proportion of variance explained; Thyroid carcinoma; Validating staging classifications

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; DISEASE COURSE; HIGH RISK POPULATION; HISTOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; AGE FACTORS; CARCINOMA, PAPILLARY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; THYROID NEOPLASMS;

EID: 0030978006     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970615)79:12<2414::AID-CNCR18>3.0.CO;2-U     Document Type: Article

References (30)

1. Hermanek P, Sobin LH. UICC: TNM classification of malignant tumours. 4th edition. Berlin: Springer-Verlag, 1987.
2. Beahrs O, Henson D, Hutter R, Myers M. Manual for staging of cancer. 3rd edition. Philadelphia: J.B. Lippincott, 1988.
3. Hermanek P, Sobin LH, Fleming ID. What do we need beyond TNM? Cancer 1996;77(5):815-7.
4. Tsang RS, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The role of radiation therapy in differentiated thyroid cancer [abstract] Thyroid 1995;5:S217.
5. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
6. Peto R, Pike M, Armstrong P, Breslow N, Cox D, Howard S, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 1977;35:1-39.
7. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19(3):545-76.
8. Schemper M. The relative importance of prognostic factors in studies of survival. Stat Med 1993;12:2377-82.
9. Collet D. Modelling survival data in medical research. London: Chapman & Hall, 1994.
10. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033-41.
11. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104(6):947-53.
12. Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;43:810-20.
13. Cady B, Rossi R, Silverman M, Wool M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985;98(6):1171-8.
14. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114(6):1050-8.
15. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-30.
16. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71(2):414-24.
17. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
18. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 1994;116(6):1036-41.
19. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-61.
20. Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg 1994;18(4):552-8.
21. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993;72(9):2680-5.
22. Gospodarowicz MK, O'Sullivan B, Berkel HJ, Beatty DJ. Staging of cancer revisited. Can Med Assoc J 1994;150(5):663-5.
23. Fielding LP, Fenoglio-Preiser CM, Freedman LS. The future of prognostic factors in outcome prediction for patients with cancer. Cancer 1992;70(9):2367-77.
24. Harrell FE, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems and suggested solutions. Cancer Treat Rep 1985;69(10):1071-7.
25. Shipp MA, Project TIN-HLPF. A predictive model for aggressive non-Hodgkins' lymphoma. N Engl J Med 1993;329(14):987-94.
26. Mead GM. International consensus prognostic classification for metastatic germ cell tumours treated with platinum based chemotherapy: final report of the International Germ Cell Cancer Collaborative Group (IGCCCG) In: Perry MC, editor. Proceedings of the American Society of Clinical Oncology Annual Meeting. Los Angeles: ASCO, 1995:235.
27. Davis NL, Bugis SP, McGregor GI, Germann E. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. Am J Surg 1995;170:476-80.
28. Jones GW, Browman G, Goodyear M, Marcellus D, Hodson I. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck 1993;15:497:497-503.
29. Lee AWM, Foo W, Poon YF, Law CK, Chan DKK, O SK, et al. Staging of nasopharyngeal carcinoma: evaluation of n-staging by Ho and UICC/AJCC Systems. Clin Oncol (R Coll Radiol) 1996;8:146-54.
30. Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer: pitfalls of applying the results of published studies to another population. Cancer 1986;58:1749-55.